Table 2.
Distribution of Antimicrobial Resistance Among Gut Commensal E. coli Isolates
| Antimicrobial Agent | Sensitive No. (%)a | Resistant No. (%)a |
|---|---|---|
| Ampicillin | 14 (25) | 42 (75) |
| Amoxicillin-clavulanate | 19 (33.9) | 37 (66.1) |
| Cefoxitin | 26 (46.4) | 30 (53.6) |
| Ceftriaxone | 15 (26.8) | 41 (73.2) |
| Cefuroxime | 16 (28.6) | 40 (71.4) |
| Ceftazidime | 16 (28.6) | 40 (71.4) |
| Cefepime | 17 (30.4) | 39 (69.6) |
| Aztreonam | 16 (28.6) | 40 (71.4) |
| Ciprofloxacin | 21 (37.5) | 35 (62.5) |
| Levofloxacin | 21 (37.5) | 35 (62.5) |
| Gentamicin | 32 (57.1) | 24 (42.9) |
| Amikacin | 38 (67.9) | 18 (32.1) |
| Tetracycline | 25 (44.6) | 31 (55.4) |
| Trimethoprim/sulfamethoxazole | 14 (25) | 42 (75) |
Note: aPercentage correlated to the total number of commensal isolates (n = 56).
Abbreviation: E. coli, Escherichia coli.